Dr. Li received her ScM in Epidemiology from Johns Hopkins University and her PhD in Pharmaceutical Outcomes Research & Policy from University of Washington. She completed a two-year postdoctoral fellowship at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California. Her research interests include defining and measuring novel elements of value for medical technologies, pharmaceutical pricing, and evaluating the impact of new drug innovations on population health and equity.
